Safety of Drug Imports Questioned
With an ever-larger percentage of prescription drugs and drug ingredients coming to the U.S. market from developing nations such as China and India, Congress is voicing concern that the number of inspections of those plants by the Food and Drug Administration has grown far more slowly.-

